Skip to main content
PMC home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1995 Nov;4(6):437–443. doi: 10.1155/S0962935195000706

Cytotoxicity towards human endothelial cells, induced by neutrophil myeloperoxidase: protection by ceftazidime

M Mathy-Hartert 1,✉, G Deby-Dupont 1,2, C Deby 1, L Jadoul 3, A Vandenberghe 3, M Lamy 1,2
PMCID: PMC2365676  PMID: 18475677

Abstract

We investigated the effects of the antibiotic ceftazidime (CAZ) on the cytolytic action of the neutrophil myeloperoxidase–hydrogen peroxide–chloride anion system (MPO/H2O2/Cl−). In this system, myeloperoxidase catalyses the conversion of H2O2 and CI− to the cytotoxic agent HOCl. Stimulated neutrophils can release MPO into the extracellular environment and then may cause tissue injury through direct endothelial cells lysis. We showed that human umbilical vein endothelial cells (HUVEC) were capable of taking up active MPO. In presence of H2O2 (10−4 M), this uptake was accompanied by cell lysis. The cytolysis was estimated by the release of 51Cr from HUVEC and expressed as an index of cytotoxicity (IC). Dose dependent protection was obtained for CAZ concentrations ranging from 10−5 to 10−3 M;this can be attributed to inactivation of HOCl by the drug. This protection is comparable to that obtained with methionine and histidine, both of which are known to neutralize HOCl. This protection by CAZ could also be attributed to inactivation of H2O2, but when cytolysis was achieved with H2O2 or O2- generating enzymatic systems, no protection by CAZ was observed. Moreover, the peroxidation activity of MPO (action on H2O2) was not affected by CAZ, while CAZ prevented the chlorination activity of MPO (chlorination of monochlorodimedon). So, we concluded that CAZ acts via HOCl inactivation. These antioxidant properties of CAZ may be clinically useful in pathological situations where excessive activation of neutrophils occurs, such as in sepsis.

Full Text

The Full Text of this article is available as a PDF (747.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ager A., Gordon J. L. Differential effects of hydrogen peroxide on indices of endothelial cell function. J Exp Med. 1984 Feb 1;159(2):592–603. doi: 10.1084/jem.159.2.592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Allen R. C., Stjernholm R. L., Steele R. H. Evidence for the generation of an electronic excitation state(s) in human polymorphonuclear leukocytes and its participation in bactericidal activity. Biochem Biophys Res Commun. 1972 May 26;47(4):679–684. doi: 10.1016/0006-291x(72)90545-1. [DOI] [PubMed] [Google Scholar]
  3. Bakkenist A. R., Wever R., Vulsma T., Plat H., van Gelder B. F. Isolation procedure and some properties of myeloperoxidase from human leucocytes. Biochim Biophys Acta. 1978 May 11;524(1):45–54. doi: 10.1016/0005-2744(78)90101-8. [DOI] [PubMed] [Google Scholar]
  4. Cantin A., Woods D. E. Protection by antibiotics against myeloperoxidase-dependent cytotoxicity to lung epithelial cells in vitro. J Clin Invest. 1993 Jan;91(1):38–45. doi: 10.1172/JCI116196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cipolle M. D., Pasquale M. D., Cerra F. B. Secondary organ dysfunction. From clinical perspectives to molecular mediators. Crit Care Clin. 1993 Apr;9(2):261–298. [PubMed] [Google Scholar]
  6. Deby-Dupont G., Croisier J. L., Camus G., Brumioul D., Mathy-Hartert M., Sondag D., Deby C., Lamy M. Inactivation of alpha(2)-Macroglobulin by Activated Human Polymorphonuclear Leukocytes. Mediators Inflamm. 1994;3(2):117–123. doi: 10.1155/S0962935194000141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gunther M. R., Mao J., Cohen M. S. Oxidant-scavenging activities of ampicillin and sulbactam and their effects on neutrophil functions. Antimicrob Agents Chemother. 1993 May;37(5):950–956. doi: 10.1128/aac.37.5.950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hager L. P., Morris D. R., Brown F. S., Eberwein H. Chloroperoxidase. II. Utilization of halogen anions. J Biol Chem. 1966 Apr 25;241(8):1769–1777. [PubMed] [Google Scholar]
  9. Kanofsky J. R., Wright J., Miles-Richardson G. E., Tauber A. I. Biochemical requirements for singlet oxygen production by purified human myeloperoxidase. J Clin Invest. 1984 Oct;74(4):1489–1495. doi: 10.1172/JCI111562. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Khan A. U. Myeloperoxidase singlet molecular oxygen generation detected by direct infrared electronic emission. Biochem Biophys Res Commun. 1984 Jul 31;122(2):668–675. doi: 10.1016/s0006-291x(84)80085-6. [DOI] [PubMed] [Google Scholar]
  11. Klebanoff S. J., Hamon C. B. Role of myeloperoxidase-mediated antimicrobial systems in intact leukocytes. J Reticuloendothel Soc. 1972 Aug;12(2):170–196. [PubMed] [Google Scholar]
  12. Lapenna D., Cellini L., De Gioia S., Mezzetti A., Ciofani G., Festi D., Cuccurullo F. Cephalosporins are scavengers of hypochlorous acid. Biochem Pharmacol. 1995 May 11;49(9):1249–1254. doi: 10.1016/0006-2952(95)00044-z. [DOI] [PubMed] [Google Scholar]
  13. Matheson N. R., Wong P. S., Travis J. Enzymatic inactivation of human alpha-1-proteinase inhibitor by neutrophil myeloperoxidase. Biochem Biophys Res Commun. 1979 May 28;88(2):402–409. doi: 10.1016/0006-291x(79)92062-x. [DOI] [PubMed] [Google Scholar]
  14. Miyachi Y., Yoshioka A., Imamura S., Niwa Y. Effect of antibiotics on the generation of reactive oxygen species. J Invest Dermatol. 1986 Apr;86(4):449–453. doi: 10.1111/1523-1747.ep12285793. [DOI] [PubMed] [Google Scholar]
  15. Neuhof H. Actions and interactions of mediator systems and mediators in the pathogenesis of ARDS and multiorgan failure. Acta Anaesthesiol Scand Suppl. 1991;95:7–14. doi: 10.1111/j.1399-6576.1991.tb03394.x. [DOI] [PubMed] [Google Scholar]
  16. Odell E. W., Segal A. W. The bactericidal effects of the respiratory burst and the myeloperoxidase system isolated in neutrophil cytoplasts. Biochim Biophys Acta. 1988 Oct 7;971(3):266–274. doi: 10.1016/0167-4889(88)90141-3. [DOI] [PubMed] [Google Scholar]
  17. Rains C. P., Bryson H. M., Peters D. H. Ceftazidime. An update of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy. Drugs. 1995 Apr;49(4):577–617. doi: 10.2165/00003495-199549040-00008. [DOI] [PubMed] [Google Scholar]
  18. Reddy V. Y., Pizzo S. V., Weiss S. J. Functional inactivation and structural disruption of human alpha 2-macroglobulin by neutrophils and eosinophils. J Biol Chem. 1989 Aug 15;264(23):13801–13809. [PubMed] [Google Scholar]
  19. Weiss S. J. Tissue destruction by neutrophils. N Engl J Med. 1989 Feb 9;320(6):365–376. doi: 10.1056/NEJM198902093200606. [DOI] [PubMed] [Google Scholar]
  20. Zabucchi G., Soranzo M. R., Menegazzi R., Bertoncin P., Nardon E., Patriarca P. Uptake of human eosinophil peroxidase and myeloperoxidase by cells involved in the inflammatory process. J Histochem Cytochem. 1989 Apr;37(4):499–508. doi: 10.1177/37.4.2538504. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES